drug
CFI-402411
Phase 2updated 3mo agoby Treadwell Therapeutics Inc
Phase 2community read0 votes
indications
indications
NSCLCMelanoma
all catalysts(0)
nothing on the calendar yet
Trials studying CFI-402411
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 37m ago
Found something off?
comments(0)
5-min edit window · permanent after that